Tuesday, January 18, 2011

Allscripts-Misys (NASDAQ:MDRX) Positioned to Compete in Physician, Hospital EHR Market

Allscripts-Misys Healthcare (NASDAQ:MDRX), via their merger with Eclipsys, are now strongly positioned to compete in the hospital and physician EHR market, says UBS (NYSE:UBS).

UBS commented, "We reiterate our rating on Allscripts and are increasing our price target to $25. We think the Eclipsys merger well positions the company to compete in both the hospital and physician EHR market. Merger and technology integration has already begun, and in our view, having high profile customers already using both platforms helps ‘reference-ability’. We believe management’s long term targets may prove conservative, leading to above consensus estimates in out years."

UBS maintains a "Buy" rating Allscripts-Misys Healthcare, which closed Friday at $20.82, up $0.19, or 0.92 percent, They increased their price target on them from $23 to $25.

No comments: